considerations for the implementation of novel therapies into all clinical practice
Published 3 months ago • 79 plays • Length 4:41Download video MP4
Download video MP3
Similar videos
-
0:57
novel therapeutic strategies in all
-
2:18
the development of novel treatment modalities: regulations and expectations
-
2:57
novel targeted therapies for the treatment of bpdcn
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
9:25
mgus diagnosis: a step-by-step approach
-
4:10
the management of prefibrotic myelofibrosis
-
7:25
ai in hematology: advances, challenges, and future applications
-
1:18
how our expanding knowledge of pre-malignant conditions may impact clinical decision-making
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
1:11
the treatment of aml within the united kingdom nhs framework
-
1:49
bringing precision medicine and mrd into clinical strategies
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:53
preclinical research for the future of cellular therapies
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
4:16
novel therapies for mpns
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)